Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
出版年份 2020 全文链接
标题
Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-19
DOI
10.1038/s41598-020-77186-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia
- (2020) Valentin Barsan et al. Current Oncology Reports
- Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease : Updated experience from a large‐scale study
- (2020) Si‐Ning Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation
- (2019) Yifei Cheng et al. Engineering
- Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
- (2019) Xiaodong Mo et al. Frontiers of Medicine
- The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia
- (2019) Ya-Zhen Qin et al. ANNALS OF HEMATOLOGY
- Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)
- (2019) Feifei Tang et al. Science China-Life Sciences
- Management of cytokine release syndrome related to CAR-T cell therapy
- (2019) Hongli Chen et al. Frontiers of Medicine
- Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study
- (2018) Xiao-Ji Lin et al. ANNALS OF HEMATOLOGY
- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
- (2018) Gerrit J. Schuurhuis et al. BLOOD
- The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
- (2018) Lanping Xu et al. Journal of Hematology & Oncology
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation
- (2018) Xiaodong Mo et al. Frontiers of Medicine
- The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
- (2018) Yu Wang et al. CANCER LETTERS
- Chimeric Antigen Receptor T-Cell Therapy
- (2018) Ndiya Ogba et al. Journal of the National Comprehensive Cancer Network
- Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study
- (2018) Xiao‐Dong Mo et al. ONCOLOGIST
- Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission
- (2018) Yang Liu et al. Science China-Life Sciences
- The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
- (2018) Xiao-Dong Mo et al. Science Bulletin
- Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- (2018) Sebastian Giebel et al. BONE MARROW TRANSPLANTATION
- Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
- (2018) S. Modvig et al. LEUKEMIA
- Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect
- (2017) Guillermo Orti et al. EXPERIMENTAL HEMATOLOGY
- Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation
- (2016) Pu Kuang et al. LEUKEMIA & LYMPHOMA
- Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation
- (2016) Masahiko Sumi et al. LEUKEMIA & LYMPHOMA
- Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
- (2015) Xiao-Dong Mo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
- (2015) C-H Yan et al. BONE MARROW TRANSPLANTATION
- Who is the best donor for a related HLA haplotype-mismatched transplant?
- (2014) Y. Wang et al. BLOOD
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
- (2014) P. Armand et al. BLOOD
- Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
- (2013) Xiao-su Zhao et al. ANNALS OF HEMATOLOGY
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- Diagnosis and management of acute graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis and management of chronic graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Human interferon-alpha increases the cytotoxic effect of CD56+cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines
- (2012) Ludovic Durrieu et al. CYTOTHERAPY
- Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
- (2012) Huan Chen et al. Journal of Hematology & Oncology
- Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-α2b and granulocyte-macrophage colony-stimulating factor
- (2012) Leonid Volodin et al. LEUKEMIA & LYMPHOMA
- Wilms’ tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
- (2011) X-S Zhao et al. BONE MARROW TRANSPLANTATION
- Interferon-α in acute myeloid leukemia: an old drug revisited
- (2011) S Anguille et al. LEUKEMIA
- Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia
- (2010) S. Heesch et al. HAEMATOLOGICA
- Interferon- induces the growth inhibition of human T-cell leukaemia line Jurkat through p38 and p38
- (2010) W. H. Lee et al. JOURNAL OF BIOCHEMISTRY
- Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic Malignancies
- (2009) H. Xiao-Jun et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started